Search

everythinglearnresearchcommunity

for

Search:↓

Some babies are born with alopecia areata, and a treatment with clobetasol propionate can regrow hair in half of the cases.

Some people with heavy hair shedding might actually have a hidden form of alopecia, which can be identified by specific hair changes.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

308-nm excimer laser therapy helps regrow hair in alopecia areata.

Hair loss in lupus is different from hair loss in alopecia areata and may indicate lupus activity.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Arachidonic acid helps hair grow by increasing growth factors and improving follicle health.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Quercetin effectively treated and prevented hair loss in mice.

The condition called 'acute diffuse and total alopecia of the female scalp' is actually a known condition named alopecia areata incognita.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Low vitamin D can worsen pediatric alopecia areata.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

The combined therapy was effective and safe for children with severe alopecia areata.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Gene therapy, especially using atoh1, shows promise for creating functional sensory hair cells in the inner ear, but dosing and side effects need to be managed for clinical application.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Immune cells affect hair growth and could lead to new hair loss treatments.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Diphencyprone helped most patients with alopecia areata regrow some hair.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.